Giovanni Lentini was born in Lecce (1961). Lentini studied medicinal chemistry and technologies at the University of Bari where he received his degree with maximum vote and honor (1986). During his Ph.D. studies, he was a Visiting Scientist at the Centre de Neurochimie du Centre Nationale de la Recherche Scientifique (CNRS) in Strasbourg. There, he spent one year in the Molecular Medicinal Chemistry Laboratory directed by Professor Camille-Georges Wermuth, under whose tutoring he got his Diploma in Advanced Studies (Diplôme d’Etudes Approfondies, DEA) in pharmacology in the field: medicinal chemistry. Back in Italy, he got his Ph.D. degree in medicinal chemistry in 1991. As a secondary school teacher of chemistry (1990-1992), he was appointed first as a Researcher (Medicinal Chemistry Department, 1992) and then as an Associate Professor (Faculty of Pharmacy, 2001) at the University of Bari, where he teaches Medicinal and Toxicological Chemistry I (Pharmacy). His main research themes focus on chiral biologically active compounds with the aim to exploit chirality in order to gain pharmacological dissociation in promiscuous drugs. He is the inventor of a voltage gated sodium channel inhibitor, delivered by Sigma RBI (section ion channels, code number: M 0814). Since 1987, he has been a Member of the Italian Chemical Society and since 2004 an Expert of the Panel for the Evaluation of the National Research (VTR) of the Italian Education, University, and Research Ministry (MIUR). Since his appointment at the Faculty of Pharmacy, he has been a teacher of the research doctorate on medicinal chemistry. He contributed to the translation of four books in the domain of medicinal chemistry and, since 2003, has been an Expert of the Italian Health Ministry for the Continuing Medical Education (CME) program.
Biography Updated on 14 January 2015